Adeel Kaiser, MD

Adeel Kaiser, MD

Dr. Kaiser is an assistant professor of Radiation Oncology at the University of Maryland School of Medicine. He received both his undergraduate and medical degrees from Johns Hopkins University. He completed his residency training at the University of California Irvine Integrated Program in Radiation Oncology, where he also served as Chief Resident. His training included over one year of clinical and research experience at the City of Hope National Cancer Center in southern California.

Dr. Kaiser’s primary research focus involves the development and clinical integration of metabolic therapy strategies for cancer patients. This holistic approach is intended to enhance the effectiveness of current treatments by taking advantage of the differences in the metabolisms of cancer cells and normal cells. In 2016, he was awarded a grant by the Mid-Atlantic Nutrition and Obesity Research Center to investigate the impact of dietary changes on patients with prostate cancer. Dr. Kaiser is also working to organize such complementary treatments into a defined therapeutic pathway called “The C.O.M.P.L.E.T.E. Program,” or Comprehensive Oncologic Management of Patients by Linking Eating, Therapy and Exercise. The C.O.M.P.L.E.T.E. Program will aim at maximizing cancer treatment outcomes while also improving the overall well-being of patients. In addition to this research focus, Dr. Kaiser is also involved in a number of clinical trials utilizing proton therapy for a variety of different cancers.

Dr. Kaiser’s Publications: https://www.researchgate.net/profile/Adeel_Kaiser2/publications


Related Videos

The Latest Developments in Prostate Imaging at UMMC Video

The Latest Developments in Prostate Imaging at UMMC

Researchers like the University of Maryland Medical Center are exploring the use of MRI-ultrasound fusion and metabolic imaging to allow for targeted biopsy of suspicious tissues.

The Latest Developments in Prostate Imaging at UMMC Video

The Latest Developments in Prostate Imaging at UMMC

Researchers like the University of Maryland Medical Center are exploring the use of MRI-ultrasound fusion and metabolic imaging to allow for targeted biopsy of suspicious tissues.